Navigation Links
Finesse Announces TruDO Optical Autoclavable Sensors for Bioprocess Applications
Date:12/17/2008

SANTA CLARA, Calif., Dec. 17 /PRNewswire/ -- Finesse Solutions, LLC, a manufacturer of measurement and control solutions for life science process applications, announced the introduction of an autoclavable optical dissolved oxygen sensor that gives better performance and requires less maintenance than traditional DO sensors currently used in the industry.

"Our new TruDO Optical sensor ushers in next-generation sensor technologies for bioprocess applications," said Finesse CTO Dr. Mark Selker. Currently available for evaluation, TruDO sensors and accessories will be generally commercially available in January 2009.

A direct replacement for traditional polargraphic DO sensors, TruDO Optical sensors use phase fluorimetry to measure dissolved oxygen. Their optical approach provides three key benefits: faster measurement response time, minimal long-term drift and lower cost. TruDO Optical sensors reduce operating costs because they do not require polarization or electrolyte solution. They also lower capital costs as they do not require a transmitter: they can output a 4 to 20 mA analog or ModBus digital signal directly to the bioreactor controller. Additionally, they can be used as a drop-in replacement for an electrochemical probe, by emulating an output current in nA to an existing transmitter.

TruDO Optical sensors have a VarioPin connection on a Pg13.5 threaded cap, a 12 mm diameter, and are available in 120 mm, 160 mm, 225 mm, 325 mm and 425 mm lengths. The TruDO Optical family of products will also include cables, housings, replacement optical caps and power converters.

"TruDO Optical enhances our reusable sensor product family and brings new capabilities along with greater ease of use," Dr. Selker added. "With the recent introduction of TruFluor, an innovative next-generation single-use optical DO sensor, Finesse offers both single-use and reusable DO sensor solutions to
'/>"/>

SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Applikon and Finesse Solutions Introduce TruConnect(TM)
2. John OConnell Joins Finesse Solutions as Vice-President of Sales and Business Development
3. Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
4. Baxa Announces 2009 Course Dates for Its STAR Center(R) Training Facility
5. Forest Laboratories Announces Executive Exercised Stock Options With Intent to Hold Shares
6. URAC Announces Revised Case Management Accreditation Standards and Measures
7. Integrative Medicine Expert Announces New Book: Armageddon of the Mind
8. BELLUS Health announces formal notice to voluntarily delist from NASDAQ
9. SynCare Announces Ian Duncan Joins Board of Directors
10. B2B Marketing Pro Toby Younis Announces Free Webcast on "BuzzMaking"
11. Strategic Domain Announces 30-Point Search Engine Optimization Check-up for Web Sites

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , Sponsored by Merck, the unique online a...icipants in their HIV treatment decisions ,, A...- TheBody ( www.thebody.com ), the #1 HIV/AIDS res... online and mobile tool offering HIV/AIDS-infected...heir medical data. The tool, created with sponsors...
(Date:11/30/2009)... , Study Uses Tent To Si...EW YORK, Nov. 30 Distan...gen levels are known to improve their performance ... heart failure patients, who suffer from fatigue, ... tent-like, high-altitude simulator? ,, That is...
(Date:11/30/2009)... , NEW YORK, Nov. 30 O...tates who are living with HIV/AIDS, nearly half ar...on rates in Washington, D.C. have surpassed the th... Black women account for more than 90 percent of a...apitol. On Tuesday, December 1 at 6:00 p.m.*, Worl...
(Date:11/30/2009)...ere is a tiny period of time between the registrat...nd our conscious recognition of it ― between...e it as an apple. Our minds lag behind our eyes, b...ions to the world around us? , Some estimates ...hers say 500 milliseconds. A new study by Tel Aviv...
(Date:11/30/2009)... Keynote speaker & Author... , Corpus Christi, TX (Vo...Autism Conference is set to be held in Corpus Chr...ecember 5, 2009 at the American Bank Center., , ,...is expected to make a nearly $300,000 economic imp...
Breaking Medicine News(10 mins):Health News:TheBody.com Launches My Health Tracker, Enabling HIV-Positive Patients to Track Lab Results, Medications and Supplements 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 2Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 3Health News:Can Exposure to Low Oxygen Levels Benefit Heart Failure Patients? 4Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 2Health News:BET Networks Joins the International Call to Stop the Spread of HIV on World Aids Day Tuesday, December 1 with an Annual Special Episode of '106 & PARK' and on the Ground Initiatives Through BET's Award Winning Public Affairs Campaign Rap-It-Up 3Health News:Now you see it, now you know you see it 2Health News:18th Annual Texas Autism Conference Returns To Corpus Christi, Makes Nearly $300,000 Economic Impact 2
...Partner, Paladin, Enters Into Co- Pr...C, Feb. 1 /PRNewswire-FirstCall/ - Labopharm Inc. ...anadian licensing and distribution,partner for its...ada Inc. The agreement will double the number of p...
...y joy and goodwill that,epitomise Christmas and th...tions, letdowns, tension and, not least, drinking ... of the year for someone with alcohol,issues: offi... the merriment of Christmas and the New Year masks...
...ir Employee Health Benefit Plans Stack Up, PARSIP...ource executives grappling with ways to keep their...t effective found out how their plans,compare to o... Benefit Sources & Solutions in Bound Brook,presen...
...creased chances by 85%, study finds , , T...f sugar-sweetened soft drinks and fructose is stro..., a new study says. , Gout, caused by excess uric ...ates over the past few decades. , In this study, p...
...el drug romiplostim (Nplate) show that it signific...ronic immune thrombocytopenic purpura (ITP), a hem...ding. An international research team reports Phas... the February 2 issue of The Lancet. , Many ITP ...
...Office of Management and Budget evaluates research...ther federal agencies using the Program Assessment...agencies about many aspects of their programs, inc...effective, or somewhere in between. An "ineffecti...
Other Medicine News:Health News:Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly 2Health News:Canadian Marketing and Sales Effort for Labopharm's Once-Daily Tramadol Product to Expand Significantly 3Health News:A Festive White Knuckle Ride? 2Health News:Key to Attracting and Retaining Quality Employees: Benefits 2Health News:Key to Attracting and Retaining Quality Employees: Benefits 3Health News:Sugary Soft Drinks Boost Gout Risk in Men 2Health News:Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder 2Health News:Changes needed in how federal government evaluates efficiency of research at EPA, other agencies 2
(Date:11/30/2009)...-- Amoena USA Corporation, the worldwide leader of...the 4th Annual Breast Cancer Survivors Cruise. In ...ors and the people who helped them through their r...ost inspirational story to tell. ,, As part of ...ers who bravely endured treatments; women who, des...
(Date:11/30/2009)... 30 Optoacoustics has announced,av...phone, the most advanced,optical microphone availa...ng,(fMRI) environments. , The third gener...ber,optic microphone technology, providing the cle...ve noise cancelling. The FOMRI-III also introduces...
(Date:11/30/2009)...re/ -- Intelliject, Inc. today announced an exclus...pinephrine auto-injector, in the U.S. and Canada t...hall be responsible for manufacturing and commerci... on-going development and for obtaining U.S. regul...on rights in the territory. ,, Sanofi-aventis U...
Breaking Medicine Technology:Amoena and Young Survival Coalition Celebrate Breast Cancer Survivors With Contest and Cruise 2New Generation Noise Cancelling Optical Microphone Paves Way for Advanced Brain and Speech Research 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 1FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 2FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 3FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 4FDA Grants First Authorization of a Commercial 2009 H1N1 Flu Test for use During Pandemic Flu Emergency to Quest Diagnostics Focus Diagnostics Busines 13192 5UTMB study identifies women at risk of gaining excessive weight with injectable birth control 9351 1UTMB study identifies women at risk of gaining excessive weight with injectable birth control 9351 2Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 1Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 2Back to School Health 3A Are Your Childs Eyes Ready for the Classroom 3F 52683 3
...sis of Pivotal Trial to Be Available No Later Than...asdaq:,FVRL), a biopharmaceutical company developi...e treatment of cancer, announced that an independe...ed to assess time to tumor,progression (TTP) for p...tal Phase 3 clinical trial of FavId(R). The DMB as...
...stent with MKC-1 Akt-mTOR Inhibitor Mechanism, RO...MD ), a clinical-stage pharmaceutical company deve...d inflammatory diseases, today,announced the prese...KC-1,in preclinical renal cell carcinoma (RCC) mod...RTC International Conference on Molecular,Targets ...
Other Medicine Technology:Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 2Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 3Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 4Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 5Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 6Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 7Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 8Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results 9EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 2EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 3EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model 4
Kelman-McPherson Angled Suturing-Corneal Forceps
Lieberman Suturing Forceps
Watzke Sleeve Spreading Forceps
Castroviejo Suture Forceps
Medicine Products: